Global and Japan Influenza Drugs and Vaccines Market Insights, Forecast to 2026

Global and Japan Influenza Drugs and Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Influenza Drugs and Vaccines Product Introduction
1.2 Market Segments
1.3 Key Influenza Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir Phosphate
1.4.4 Peramivir
1.4.5 Trivalent
1.4.6 Quadrivalent
1.5 Market by Application
1.5.1 Global Influenza Drugs and Vaccines Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Research Laboratories
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Influenza Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Influenza Drugs and Vaccines Revenue 2015-2026
2.1.2 Global Influenza Drugs and Vaccines Sales 2015-2026
2.2 Global Influenza Drugs and Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Influenza Drugs and Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Influenza Drugs and Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Influenza Drugs and Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Influenza Drugs and Vaccines Revenue Forecast by Region (2021-2026)
3 Global Influenza Drugs and Vaccines Competitor Landscape by Players
3.1 Global Top Influenza Drugs and Vaccines Sales by Manufacturers
3.1.1 Global Influenza Drugs and Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Influenza Drugs and Vaccines Manufacturers by Revenue
3.2.1 Global Influenza Drugs and Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Drugs and Vaccines Revenue in 2019
3.2.5 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Influenza Drugs and Vaccines Price by Manufacturers
3.4 Global Influenza Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Drugs and Vaccines Market Size by Type (2015-2020)
4.1.1 Global Influenza Drugs and Vaccines Sales by Type (2015-2020)
4.1.2 Global Influenza Drugs and Vaccines Revenue by Type (2015-2020)
4.1.3 Influenza Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Drugs and Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Influenza Drugs and Vaccines Market Size by Application (2015-2020)
5.1.1 Global Influenza Drugs and Vaccines Sales by Application (2015-2020)
5.1.2 Global Influenza Drugs and Vaccines Revenue by Application (2015-2020)
5.1.3 Influenza Drugs and Vaccines Price by Application (2015-2020)
5.2 Influenza Drugs and Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Drugs and Vaccines Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
6.1.1 Japan Influenza Drugs and Vaccines Sales YoY Growth 2015-2026
6.1.2 Japan Influenza Drugs and Vaccines Revenue YoY Growth 2015-2026
6.1.3 Japan Influenza Drugs and Vaccines Market Share in Global Market 2015-2026
6.2 Japan Influenza Drugs and Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Influenza Drugs and Vaccines Players by Sales (2015-2020)
6.2.2 Japan Top Influenza Drugs and Vaccines Players by Revenue (2015-2020)
6.3 Japan Influenza Drugs and Vaccines Historic Market Review by Type (2015-2020)
6.3.1 Japan Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
6.3.2 Japan Influenza Drugs and Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 Japan Influenza Drugs and Vaccines Price by Type (2015-2020)
6.4 Japan Influenza Drugs and Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Influenza Drugs and Vaccines Sales Forecast by Type (2021-2026)
6.4.2 Japan Influenza Drugs and Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 Japan Influenza Drugs and Vaccines Price Forecast by Type (2021-2026)
6.5 Japan Influenza Drugs and Vaccines Historic Market Review by Application (2015-2020)
6.5.1 Japan Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
6.5.2 Japan Influenza Drugs and Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 Japan Influenza Drugs and Vaccines Price by Application (2015-2020)
6.6 Japan Influenza Drugs and Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Influenza Drugs and Vaccines Sales Forecast by Application (2021-2026)
6.6.2 Japan Influenza Drugs and Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 Japan Influenza Drugs and Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
7.2 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
7.2.1 North America Influenza Drugs and Vaccines Sales by Country (2015-2020)
7.2.2 North America Influenza Drugs and Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
8.2.1 Europe Influenza Drugs and Vaccines Sales by Country
8.2.2 Europe Influenza Drugs and Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country
10.2.1 Latin America Influenza Drugs and Vaccines Sales by Country
10.2.2 Latin America Influenza Drugs and Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Influenza Drugs and Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country
11.2.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Sanofi Pasteur
12.2.1 Sanofi Pasteur Corporation Information
12.2.2 Sanofi Pasteur Description and Business Overview
12.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
12.2.5 Sanofi Pasteur Recent Development
12.3 CSL Limited
12.3.1 CSL Limited Corporation Information
12.3.2 CSL Limited Description and Business Overview
12.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Limited Influenza Drugs and Vaccines Products Offered
12.3.5 CSL Limited Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Corporation Information
12.4.2 Astrazeneca Description and Business Overview
12.4.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Astrazeneca Influenza Drugs and Vaccines Products Offered
12.4.5 Astrazeneca Recent Development
12.5 Protein Sciences Corporation
12.5.1 Protein Sciences Corporation Corporation Information
12.5.2 Protein Sciences Corporation Description and Business Overview
12.5.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
12.5.5 Protein Sciences Corporation Recent Development
12.6 Serum Institute Of India Pvt. Ltd.
12.6.1 Serum Institute Of India Pvt. Ltd. Corporation Information
12.6.2 Serum Institute Of India Pvt. Ltd. Description and Business Overview
12.6.3 Serum Institute Of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Products Offered
12.6.5 Serum Institute Of India Pvt. Ltd. Recent Development
12.7 Emergent Biosolutions
12.7.1 Emergent Biosolutions Corporation Information
12.7.2 Emergent Biosolutions Description and Business Overview
12.7.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
12.7.5 Emergent Biosolutions Recent Development
12.8 Emergent Biosolutions
12.8.1 Emergent Biosolutions Corporation Information
12.8.2 Emergent Biosolutions Description and Business Overview
12.8.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
12.8.5 Emergent Biosolutions Recent Development
12.9 BioCryst Pharmaceuticals.Inc.
12.9.1 BioCryst Pharmaceuticals.Inc. Corporation Information
12.9.2 BioCryst Pharmaceuticals.Inc. Description and Business Overview
12.9.3 BioCryst Pharmaceuticals.Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Products Offered
12.9.5 BioCryst Pharmaceuticals.Inc. Recent Development
12.10 Alvogen
12.10.1 Alvogen Corporation Information
12.10.2 Alvogen Description and Business Overview
12.10.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Alvogen Influenza Drugs and Vaccines Products Offered
12.10.5 Alvogen Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
12.11.5 GlaxoSmithKline Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Influenza Drugs and Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Influenza Drugs and Vaccines Market Segments
Table 2. Ranking of Global Top Influenza Drugs and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Influenza Drugs and Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Zanamivir
Table 5. Major Manufacturers of Oseltamivir Phosphate
Table 6. Major Manufacturers of Peramivir
Table 7. Major Manufacturers of Trivalent
Table 8. Major Manufacturers of Quadrivalent
Table 9. Global Influenza Drugs and Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Influenza Drugs and Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Influenza Drugs and Vaccines Sales by Regions 2015-2020 (K MT)
Table 12. Global Influenza Drugs and Vaccines Sales Market Share by Regions (2015-2020)
Table 13. Global Influenza Drugs and Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Influenza Drugs and Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 15. Global Influenza Drugs and Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2015-2020)
Table 17. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2019)
Table 19. Influenza Drugs and Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Influenza Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Influenza Drugs and Vaccines Price (2015-2020) (USD/MT)
Table 22. Influenza Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Influenza Drugs and Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Influenza Drugs and Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Influenza Drugs and Vaccines Sales by Type (2015-2020) (K MT)
Table 27. Global Influenza Drugs and Vaccines Sales Share by Type (2015-2020)
Table 28. Global Influenza Drugs and Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Influenza Drugs and Vaccines Revenue Share by Type (2015-2020)
Table 30. Influenza Drugs and Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Influenza Drugs and Vaccines Sales Share by Type (2021-2026)
Table 32. Global Influenza Drugs and Vaccines Sales by Application (2015-2020) (K MT)
Table 33. Global Influenza Drugs and Vaccines Sales Share by Application (2015-2020)
Table 34. Global Influenza Drugs and Vaccines Sales Share by Application (2021-2026)
Table 35. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Influenza Drugs and Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Influenza Drugs and Vaccines Sales (K MT) of Key Companies (2015-2020)
Table 39. Japan Influenza Drugs and Vaccines Sales Share by Company (2015-2020)
Table 40. Japan Influenza Drugs and Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 42. Japan Influenza Drugs and Vaccines Sales Share by Type (2015-2020)
Table 43. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Influenza Drugs and Vaccines Price (K MT) by Type (2015-2020)
Table 45. Japan Influenza Drugs and Vaccines Sales (K MT) by Type (2021-2026)
Table 46. Japan Influenza Drugs and Vaccines Sales Share by Type (2021-2026)
Table 47. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Influenza Drugs and Vaccines Revenue Share by Type (2021-2026)
Table 49. Japan Influenza Drugs and Vaccines Price (K MT) by Type (2021-2026)
Table 50. Japan Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 51. Japan Influenza Drugs and Vaccines Sales Share by Application (2015-2020)
Table 52. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Influenza Drugs and Vaccines Sales (K MT) by Application (2021-2026)
Table 54. Japan Influenza Drugs and Vaccines Sales Share by Application (2021-2026)
Table 55. Japan Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Influenza Drugs and Vaccines Revenue Share by Application (2021-2026)
Table 57. North America Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 58. North America Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 59. North America Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 61. Europe Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 62. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 63. Europe Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2015-2020) (K MT)
Table 66. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Table 69. Latin America Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 70. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2015-2020) (K MT)
Table 74. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 77. GlaxoSmithKline Corporation Information
Table 78. GlaxoSmithKline Description and Business Overview
Table 79. GlaxoSmithKline Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 81. GlaxoSmithKline Recent Development
Table 82. Sanofi Pasteur Corporation Information
Table 83. Sanofi Pasteur Description and Business Overview
Table 84. Sanofi Pasteur Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Sanofi Pasteur Product
Table 86. Sanofi Pasteur Recent Development
Table 87. CSL Limited Corporation Information
Table 88. CSL Limited Description and Business Overview
Table 89. CSL Limited Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. CSL Limited Product
Table 91. CSL Limited Recent Development
Table 92. Astrazeneca Corporation Information
Table 93. Astrazeneca Description and Business Overview
Table 94. Astrazeneca Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Astrazeneca Product
Table 96. Astrazeneca Recent Development
Table 97. Protein Sciences Corporation Corporation Information
Table 98. Protein Sciences Corporation Description and Business Overview
Table 99. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Protein Sciences Corporation Product
Table 101. Protein Sciences Corporation Recent Development
Table 102. Serum Institute Of India Pvt. Ltd. Corporation Information
Table 103. Serum Institute Of India Pvt. Ltd. Description and Business Overview
Table 104. Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Serum Institute Of India Pvt. Ltd. Product
Table 106. Serum Institute Of India Pvt. Ltd. Recent Development
Table 107. Emergent Biosolutions Corporation Information
Table 108. Emergent Biosolutions Description and Business Overview
Table 109. Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Emergent Biosolutions Product
Table 111. Emergent Biosolutions Recent Development
Table 112. Emergent Biosolutions Corporation Information
Table 113. Emergent Biosolutions Description and Business Overview
Table 114. Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Emergent Biosolutions Product
Table 116. Emergent Biosolutions Recent Development
Table 117. BioCryst Pharmaceuticals.Inc. Corporation Information
Table 118. BioCryst Pharmaceuticals.Inc. Description and Business Overview
Table 119. BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. BioCryst Pharmaceuticals.Inc. Product
Table 121. BioCryst Pharmaceuticals.Inc. Recent Development
Table 122. Alvogen Corporation Information
Table 123. Alvogen Description and Business Overview
Table 124. Alvogen Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Alvogen Product
Table 126. Alvogen Recent Development
Table 127. ABPI Corporation Information
Table 128. ABPI Description and Business Overview
Table 129. ABPI Influenza Drugs and Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. ABPI Product
Table 131. ABPI Recent Development
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Influenza Drugs and Vaccines Players
Table 136. Influenza Drugs and Vaccines Customers List
Table 137. Influenza Drugs and Vaccines Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Phosphate Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Trivalent Product Picture
Figure 7. Quadrivalent Product Picture
Figure 8. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Research Laboratories
Figure 11. Pharmacies
Figure 12. Others
Figure 13. Influenza Drugs and Vaccines Report Years Considered
Figure 14. Global Influenza Drugs and Vaccines Market Size 2015-2026 (US$ Million)
Figure 15. Global Influenza Drugs and Vaccines Sales 2015-2026 (K MT)
Figure 16. Global Influenza Drugs and Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
Figure 18. Global Influenza Drugs and Vaccines Sales Market Share by Region in 2019
Figure 19. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Figure 20. Global Influenza Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 21. Global Influenza Drugs and Vaccines Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Influenza Drugs and Vaccines Revenue in 2019
Figure 23. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Figure 25. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 26. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2015-2020)
Figure 27. Global Influenza Drugs and Vaccines Revenue Market Share by Type in 2019
Figure 28. Global Influenza Drugs and Vaccines Market Share by Price Range (2015-2020)
Figure 29. Global Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Figure 30. Global Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 31. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2015-2020)
Figure 32. Global Influenza Drugs and Vaccines Revenue Market Share by Application in 2019
Figure 33. Japan Influenza Drugs and Vaccines Sales Growth Rate 2015-2026 (K MT)
Figure 34. Japan Influenza Drugs and Vaccines Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan Influenza Drugs and Vaccines Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest Influenza Drugs and Vaccines Players Market Share by Revenue in Influenza Drugs and Vaccines in 2019
Figure 37. Japan Influenza Drugs and Vaccines Revenue Share by Type (2015-2020)
Figure 38. Japan Influenza Drugs and Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan Influenza Drugs and Vaccines Revenue Share by Application (2015-2020)
Figure 40. Japan Influenza Drugs and Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 42. North America Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 44. North America Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 45. U.S. Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 46. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 48. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 50. Europe Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 52. Europe Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 53. Germany Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 54. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 56. France Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 58. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 60. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 62. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 64. Asia Pacific Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region in 2019
Figure 66. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 67. China Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 68. China Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 70. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 72. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 74. India Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 76. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 78. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 80. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 82. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 84. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 86. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 88. Vietnam Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Influenza Drugs and Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 90. Latin America Influenza Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Influenza Drugs and Vaccines Sales Market Share by Country in 2019
Figure 92. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 93. Mexico Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 94. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Influenza Drugs and Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 96. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Influenza Drugs and Vaccines Sales Growth Rate (2015-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs